BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2018
View Archived Issues
Etanercept biosimilar approved in Japan
Read More
Phase III CORAIL study of Zepsyre does not meet primary endpoint
Read More
MNI-1038 tracer shows promise as PET-based diagnostic for neurodegeneration
Read More
FDA issues complete response letter for CAM-2038 NDA for opioid use disorder
Read More
Phase III HELIOS trial of ASP-0113 misses endpoints
Read More
FDA clears Zealand Pharma to begin phase III trials of dasiglucagon for congenital hyperinsulinism
Read More
Sanofi set to acquire Bioverativ
Read More
Merck & Co. and Idenix describe novel HCV RNA polymerase NS5B inhibitors
Read More
The University of Kentucky patents prostaglandin E synthase inhibitors
Read More
Avacta and OncoSec Medical establish research collaboration
Read More
Novartis to transition Arzerra for CLL to compassionate use programs outside U.S.
Read More
HDAC/histone-lysine N-methyltransferase EHMT2 inhibitors discovered at Georgia State University
Read More
Roche identifies novel anti-influenza compounds
Read More
St Jude Children's Research Hospital patents new anti-CD7 chimeric antigen receptors
Read More
[18F]THK-5351 found useful for brain injury imaging
Read More
New phase I/II trial studies mRNA vaccine BI-1361849 with checkpoint inhibitors in NSCLC
Read More
Phase II study finds sotatercept effective for anemia in lower-risk myelodysplastic syndromes
Read More
FDA grants priority review to Darzalex sBLA in newly diagnosed multiple myeloma
Read More
Akeso Bio studies AK-105 in phase I for advanced solid tumors
Read More
New phase III trial explores use of BAX-111 in pediatric severe hereditary von Willebrand disease
Read More
Dupixent approved in Japan for treatment of atopic dermatitis
Read More
Moderna Therapeutics begins phase I trial of mRNA-1653
Read More
